Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors
M. Pekkarinen, K. Nordfors, J. Uusi-Makela, V. Kytola, M. Rauhala, H. Urhonen, S. Hayrynen, E. Afyounian, O. Yli-Harja, W. Zhang, P. Helen, O. Lohi, H. Haapasalo, J. Haapasalo, M. Nykter, J. Kesseli, K. J. Rautajoki
Abstract
Atypical teratoid/rhabdoid tumors (AT/RTs) are pediatric brain tumors known for their aggressiveness, exceptionally low mutation rate, and aberrant but still unresolved epigenetic regulation. To evaluate methylation associated regulation in AT/RTs, we compared them to medulloblastomas and choroid plexus tumors by integrating DNA methylation (507 samples), gene expression (120 samples), and public transcription factor (TF) binding data. We showed that elevated DNA methylation masks the binding sites of TFs driving neural development and is associated with reduced transcription for specific neural regulators in AT/RTs. Part of the hypermethylated sites behaved similarly in AT/RTs and pluripotent stem cells, revealing DNA methylation -driven halted cell differentiation. AT/RT-unique DNA hypermethylation was associated with polycomb repressive complex 2 members, like EZH2, and linked to suppressed genes with a role in neural development and tumorigenesis. The obtained results highlight and characterize these DNA methylation programs as drivers of AT/RT malignancy.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The loss of ATRX/DAXX complex disturbs rDNA heterochromatinization and promotes development of glioma
- The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft models
Anupa Geethadevi, Nikhil Vaidya, … Rhoda M. Alani·Neuro-OncologyPeer-reviewed·Jul 21, 2026
- Mirdametinib and abemaciclib cooperate in atypical teratoid rhabdoid tumor to decrease proliferation and suppress tumor growth
Jinming Liang, Yiming Deng, … Eric H. Raabe·bioRxiv·Mar 27, 2026
- Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes
Martin V. Hamann, Shweta Godbole, … Julia E. Neumann·Acta Neuropathologica CommunicationsPeer-reviewed·Jul 22, 2025
- SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
A. D. Parisian, T. Koga, … F. Furnari·bioRxiv·May 4, 2020
- MET inhibition exploits conserved regulatory dependencies in malignant rhabdoid tumors
Ines Sentis, Alex Cebria-Xart, … Alexandra Avgustinova·bioRxiv·Nov 4, 2026